Clinical influences on antibiotic prescribing decisions for lower respiratory tract infection: a nine country qualitative study of variation in care by Brookes-Howell, Lucy et al.
Clinical inﬂuences on antibiotic
prescribing decisions for lower
respiratory tract infection: a nine country
qualitative study of variation in care
Lucy Brookes-Howell,
1 Kerenza Hood,
1 Lucy Cooper,
2 Samuel Coenen,
3,4
Paul Little,
5 Theo Verheij,
6 Maciek Godycki-Cwirko,
7 Hasse Melbye,
8
Jaroslaw Krawczyk,
7 Alicia Borras-Santos,
9 Kristin Jakobsen,
8 Patricia Worby,
10
Herman Goossens,
4 Christopher C Butler
11
ABSTRACT
Objectives: There is variation in antibiotic prescribing
for lower respiratory tract infections (LRTI) in primary
care that does not beneﬁt patients. This study aims to
investigate clinicians’ accounts of clinical inﬂuences on
antibiotic prescribing decisions for LRTI to better
understand variation and identify opportunities for
improvement.
Design: Multi country qualitative interview study.
Semi-structured interviews using open-ended
questions and a patient scenario. Data were subjected
to ﬁve-stage analytic framework approach
(familiarisation, developing a thematic framework from
the interview questions and emerging themes,
indexing, charting and mapping to search for
interpretations), with interviewers commenting on
preliminary reports.
Setting: Primary care.
Participants: 80 primary care clinicians randomly
selected from primary care research networks based in
nine European cities.
Results: Clinicians reported four main individual
clinical factors that guided their antibiotic prescribing
decision: auscultation, fever, discoloured sputum and
breathlessness. These were considered alongside
a general impression of the patient derived from
building a picture of the illness course, using intuition
and familiarity with the patient. Comorbidity and older
age were considered main risk factors for poor
outcomes. Clinical factors were similar across
networks, apart from C reactive protein near patient
testing in Tromsø. Clinicians developed ways to handle
diagnostic and management uncertainty through their
own clinical routines.
Conclusions: Clinicians emphasised the importance of
auscultation, fever, discoloured sputum and
breathlessness, general impression of the illness
course, familiarity with the patient, comorbidity, and
age in informing their antibiotic prescribing decisions
for LRTI. As some of these factors may be
overemphasised given the evolving evidence base,
greater standardisation of assessment and integration
of ﬁndings may help reduce unhelpful variation in
management. Non-clinical inﬂuences will also need to
be addressed.
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ARTICLE SUMMARY
Article focus
- Clinicians’ accounts of clinical inﬂuences on
antibiotic prescribing decisions for LRTI.
- Understand variation and identify opportunities
for improvement.
Key messages
- Clinicians reported four main clinical factors that
guided their antibiotic prescribing decision:
auscultation ﬁndings, fever, discoloured sputum
and breathlessness. Clinical factors were similar
across networks, apart from C reactive protein
near patient testing used in Tromsø.
- These clinical factors were considered alongside
a general impression of the patient derived from
consideration of illness course, intuition and
familiarity with the patient.
- Clinicians developed ways to handle diagnostic
and management uncertainty through their own
clinical routines.
Strengths and limitations of this study
- This is the ﬁrst study to use semi-structured
qualitative interviews to capture clinicians’ views
about LRTI management across a broad range of
contrasting European countries.
- The clinicians who participated were afﬁliated to
a research network so may not have been
representative of all general practitioners in
their country.
- Qualitative interviews gather reports of behaviour
and attitude rather than actual behaviour, but by
allowing clinicians to introduce and elaborate on
themes spontaneously, we were able to gain an
impression of the themes that held most
prominence to the clinicians themselves.
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Open Access ResearchBACKGROUND
Antibiotic resistance is increasingly impacting on
human health.
1 There is wide variation between some
European countries in antibiotic prescribing for
patients in primary care with lower respiratory tract
infection (LRTI), and antibiotic prescribing is associ-
ated with increased antimicrobial resistance.
2e4 In the
GRACE observational study of variation in antibiotic
prescribing for acute cough, Butler and colleagues
found that patients included in Bratislava, Milan,
Balatonfu ¨red, Ło ´d z and Cardiff networks were twice as
likely to be prescribed antibiotics than the overall
mean, even once variation in clinical presentation had
been taken into account. Patients included by the
Tromsø, Antwerp and Jo ¨nko ¨ping networks were four
times less likely to be prescribed antibiotics than the
overall mean.
4 However, large differences in antibiotic
prescribing did not translate to clinically important
differences in patient recovery. Trial evidence suggests
that most antibiotic prescriptions do not help such
patients to get better any quicker.
5e7 Variation in
prescribing that does not improve patients’ outcomes,
and unnecessary antibiotics help drive selection of
resistant organisms.
14
Physical examination and medical history do not
clearly differentiate clinical syndromes, aetiology and
prognosis.
8e11 However, clinical assessment is all most
primary care clinicians have to guide them, and little is
known about the routine processes clinicians follow to
gather information on patients’ signs and symptoms in
order to make management decisions. Research
exploring clinical inﬂuences on antibiotic prescribing
has largely used quantitative methods and pre-deter-
mined clinical categories.
10 12e14 There are few quali-
tative research studies exploring a deeper
understanding of the clinical factors that inﬂuence
clinicians’ prescribing decisions in LRTI. Coenen and
colleagues identiﬁed factors general practitioners
(GPs) reported using in diagnostic decisions regarding
patients with cough and also quantiﬁed the factors in
a questionnaire study.
81 5However, that study was
limited to one region in Belgium and did not provide
an in-depth description of the multiple components
which make up clinical method. Fischer and
colleagues
16 conducted a direct observational study of
family practitioners’ decision making for patients with
R T Ii nG e r m a n yb u td i dn o tp r o v i d ei n f o r m a t i o no nt h e
process and ordering of clinical factors. Furthermore,
there are no large qualitative studies that offer a wider
European comparison.
We carried out a qualitative study in nine contrasting
European countries to explore primary care clinicians’
accounts of the clinical processes that inform their
management of patients with symptoms of LRTI,
particularly in relation to decisions about antibiotic
prescribing. A further paper will report the non-clinical
factors that clinicians report as shaping prescribing
decisions.
METHODS
Setting and recruitment
We conducted semi-structured face-to-face interviews with
80 primary care clinicians in nine primary care research
networks across Europe based in the cities of: Antwerp
(10), Balatonfu ¨red (10), Barcelona (10), Cardiff (8),
Ło ´d z (10), Milan (9), Southampton (6), Tromsø (7) and
Utrecht (10). The nine networks had a track record of
conducting research and were selected to achieve
a geographical spread from 14 participating in the clinical
platform of the GRACE (Genomics to combat Resistance
against Antibiotics in Community-acquired LRTI in
Europe, http://www.grace-lrti.org) Network of Excellence
study on the presentation, management and outcome of
acute cough in Europe. Primary care clinicians were
randomly selected from participating healthcare practices
to generate a maximum target of 10 clinicians per
network. As recruitment had to be carried out locally by
facilitators within each network and individual clinician
characteristics (such as age and gender) were not avail-
able to the Cardiff research team prior to consent, it was
not possible to purposefully sample clinicians according
to speciﬁc criteria. It was therefore felt that random
sampling was more methodologically sound than conve-
nience sampling, which could be open to bias. Our study
design did not allow for us to check data saturation at the
time of data collection as there was a necessary time delay
between data collection and analysis while the interviews
were transcribed then translated into English for analysis.
However, this was taken into account when the sample
size was determined and we ensured that it was sufﬁciently
large to capture a range of contrasting experiences. A
national network facilitator oversaw recruitment, inter-
views, transcription and translation of data. Recruitment
took place between January 2007 and February 2008.
Informed written consent was taken at the point of
recruitment.
Data collection
The interview guide was developed collaboratively with
the interviewers after literature review and consideration
of the aims of the project. Interviewers were given face-
to-face training and the interview guide was revised in
the light of feedback from the pilot interviews. Study
documents required by ethics committees were trans-
lated and back translated to ensure accuracy.
Interviews were conducted in a place selected by the
participants (usually the clinician’s surgery) by the
trained interviewer in the clinician’s chosen language
and audio-recorded. Interviews were semi-structured and
consisted of four broad topic sections (factors affecting
management of patients with symptoms of LRTI,
management of patients with symptoms of LRTI, future
of management of patients with symptoms of LRTI and
attitudes to antibiotic resistance). In order to encourage
clinicians to think experientially, each clinician was also
given a typical scenario to reﬂect upondan adult patient
in their early 40s with productive cough, fever and
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normally do to diagnose the patient and decide on
treatment. The same scenario was used by all inter-
viewers to provide consistency and allow comparison and
contrast in clinicians’ responses across the different
European settings. All interviews were transcribed and
translated into English by the interviewer or translation
service when required.
Analysis
Transcripts were analysed in Cardiff using a framework
approach.
17 This ﬁve-stage approach allows themes to be
explored in relation to the prior research objectives and
for new themes to emerge from the data. The ﬁrst three
stages, ‘familiarisation’, ‘identifying a thematic frame-
work’ and ‘indexing’, are common to other forms of
qualitative data analysis. The fourth stage, ‘charting’,
involves retrieving the coded data and producing
summaries of the talk produced on each theme, for each
individual participant, and visually arranging it in a table
to build an overall picture of the whole data set. This
allowed easier comparisons across networks to identify
variation and similarities in the ﬁnal stage of interpre-
tation of data. The ﬁfth stage, ‘mapping’, involves the
research team using the charts to map and interpret the
data set as a whole and connect with the original
research objectives.
LB-H and LC developed a thematic framework on the
basis of research objectives and emerging themes, which
was revised after discussion with the Steering Group and
after being applied to more transcripts. Transcripts were
double-coded until consensus was reached. The
thematic framework was applied to data using the qual-
itative software package, NVivo 8.
18 Preliminary analytic
themes were validated by the interviewers at a workshop.
Interviewers made ﬁeldnotes after each interview,
providing contextual detail for the central research
team, and were referred to when emerging reports of
data were discussed.
Ethical considerations
Ethical approval was managed and obtained for the
qualitative study by the local facilitator within each
country. All transcripts were anonymised and identiﬁable
details deleted.
RESULTS
The gender of clinicians was balanced overall (41%
females, n¼78) with ﬁve networks interviewing more
females than male clinicians (Barcelona, Cardiff, Ło ´d z,
Milan and Southampton). The approximate age of
clinicians ranged from 30 to 67 years (mean 43 years
(n¼71)). The number of years clinicians had been in
practice ranged from not yet a full year to 33 years
(mean 16 years (n¼75)).
Clinical factors
Clinicians’ accounts revealed four clinical factors that
inﬂuenced their antibiotic prescribing decision for
LRTI. These were chest sounds on auscultation, fever,
discoloured sputum and shortness of breath. Represen-
tative quotes are followed with a code that refers to the
network and the clinicians’ unique study number.
Chest auscultation was consistently mentioned across
all nine networks as inﬂuencing clinicians’ decision to
prescribe antibiotics. Clinicians talked about auscul-
tating for a variety of sounds using descriptive concepts:
crepitations, dullness, wheeze and polyphonic wheeze,
crackles, rhonchi, whistling and mufﬂing sound, as well
as interpreting concepts: consolidation and sounds of
sputum or congestion. It was one of the ﬁrst aspects of
examination clinicians said they carried out in order to
decide the next course of action, that is, to continue with
examination, diagnose, treat the patient and consider
referral for further investigations if necessary: “Listen to
the lungs. That would be my ﬁrst step and depending on
what you then hear or what comes out of the additional
story, you have to do some more” (Utrecht 44). Clini-
cians reported that they would be more likely to
prescribe antibiotics on hearing chest sounds: “If I would
hear crepitations or rhonci or wheezing or whatever, I’d
take into account the antecedents of the patient, if it is
a chronic bronchitis patient, well managed, then I’d be
more tempted to start up antibiotics straight away”
(Antwerp 77). A clear chest also helped clinician in
deciding when antibiotics were not necessary.
However, one clinician questioned the value of relying
on auscultation in deciding whether to prescribe: “It’s
a difﬁcult issue because I don’t know that we really know
how accurate even lung signs are as a predictor so, but
you kind of get the feeling if somebody has quite focal
signs and are more unwell then.I think my threshold
for giving antibiotics at that stage might, would be lower”
(Southampton 85).
Clinicians reported that fever had an inﬂuence on
their decision to prescribe antibiotics. There was slight
variation in the duration of fever clinicians considered as
indicating that antibiotics should be prescribed. For
example, two clinicians (Antwerp 35 and 63) in the
Antwerp-based network said they might prescribe anti-
biotics if the fever has lasted 3 days and ‘still looks bad’,
while a clinician in Balatonfu ¨red (Balatonfu ¨red 286)
stated he might prescribe after 5 days of fever. Another
clinician stated that fever, alone, was not enough to
warrant prescribing antibiotics: “Even if they had a fever
and it was just a ﬂu like illness which of course is carried
round by a cough, I wouldn’t prescribe antibiotics unless
I felt there was a signiﬁcant chance of respiratory tract
infection” (Southampton 29).
The colour of sputum was mentioned by many clini-
cians across the networks as inﬂuencing decision to
prescribe, with the exception of Tromsø, and particularly
in the Southampton and Barcelona networks. The pres-
ence of yellow/green sputum was considered alongside
the nature (dense, smelly), amount (increased), usually in
relation to cough. However, three clinicians stated that
the colour of sputum was of little or no help deciding on
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these clinicians felt that there was limited evidence on
which to base decisions and therefore that coloured
sputum might still ‘steer’ a decision: “Producing coloured
sputum, that should not be taken into account when you
decide on prescribing antibiotics. But still, I take it into
account. Because like you know, as a GP, you’ve got not
a lot to base yourself on.If there is coloured sputum and
also.other worrying signs, then we are one step closer to
prescribing antibiotics” (Antwerp 77).
Some clinicians indicated that they would count the
patient’s respiratory rate and check for tachypnoea.
They also reported checking for dyspnoea, difﬁculty
breathing and rapid breathing. Some asked patients if
they had had experienced chest pain. This was then
taken into account, alongside the other clinical factors,
in deciding whether to prescribe.
Risk factors
Clinicians’ accounts revealed that they would interpret
these clinical factors in light of two major risk factors:
comorbidity and older age. Clinicians reported concern
that patients who fell into these two categories might
deteriorate rapidly and suggested that they would be
‘quicker’ to prescribe antibiotics, rather than adopting
a ‘wait and see’ approach.
Clinicians frequently reported considering patients’
comorbidity and particularly took into account chronic
obstructive pulmonary disease (COPD), as well as
asthma, circulatory disease, diabetes and heart disease:
“In the elderly, patients with COPD or heart disease, I am
more easily inclined to prescribe antibiotics, maybe from
the very start” (Milan 51). Many noted whether patients
suffered from recurrent RTIs.
Clinicians reported that older age, particularly patients
over the age of 60 or 65, was considered in the
prescribing decision: “Elderly people, however, it is
necessary more often to protect with the antibiotic. With
them more quickly, more quickly complications take
place” (Ło ´d z 106).
General impression and familiarity with the patient
Clinicians indicated that these clinical and risk factors
were combined and then considered alongside their
general impression of the patient to decide whether or
not to prescribe an antibiotic. Clinicians’ general
impressions of the patient were developed from building
up a picture of the illness course, their intuition and/or
familiarity with the patient.
Clinicians reported the need to build a picture of the
illness course. The most important features of this were
asking patients about the duration and, to a lesser
extent, severity of their symptoms. An assessment of
illness severity sometimes included an assessment of how
symptoms limited activities of daily living, such as ability
to go to work, eat and drink or walk normally. They also
considered the overall impression of how ill the patient
was. Assessments such as ‘very ill’, ‘weakened’ and ‘seri-
ously ill’ were used.
Clinicians revealed that sometimes they got ‘a feeling’
which could override the decision they would make
purely based on the clinical factors. One clinician
explained that absence of signs on auscultation might
still prompt further action if they chose to rely on their
intuition instead: “I can feel it in my bones.I can listen
to your lungs now and at this moment I don’t have any
signs.of concern, but it doesn’t give me enough
certainty.maybe further examination is needed
or.let’s give antibiotics now after all.it is a feeling
of.this is different from the routine” (Antwerp 147).
Other clinicians talked of their familiarity with the
patient, which can help them in their decision on
whether or not to prescribe antibiotics. Clinicians’
familiarity with the individual patient was important,
particularly in the Balatonfu ¨red, Ło ´d z and Cardiff
networks where over half the clinicians mentioned it.
Familiarity had a bearing on decision making in relation
to knowledge of recurrent infections (“I’m probably
more likely to prescribe earlier in patients who I know
well and who I know have had (recurrent) history”
Cardiff 98). Through familiarity with what is normal for
the patient, clinicians were able to make a more
informed evaluation of usual health status: “I have been
treating these patients for years, so in most cases I know
how the patient behaves, what he looks like in what
condition he is when he is healthy” (Ło ´d z 120). However,
while clinicians in the Balatonfu ¨red and Ło ´d z networks
indicated that this was due to continuity of care, clini-
cians in the Cardiff network talked more of performing
notes review in order to gather background medical
history.
Combining factors and zone of uncertainty
Clinicians talked about thresholds or tipping points at
which they would prescribe antibiotics: “I think the
tipping point is partly clinical and partly to do with how
ill they appear and partly to do with patient preference”
(Southampton 43). They frequently talked about
combining factors and implied that clinical factors were
given different weightings. They rarely talked about one
single factor that conclusively ‘trumped’ all other factors
in the decision to prescribe antibiotics: “the reason for
prescribing.is based upon combinations of signs and
symptoms.there is no individual cardinal symptom that
says ‘I will treat’” (Cardiff 42). Clinicians could be seen
as using their professional knowledge and attitude to
‘build up’ a diagnosis with different clinical factors
including the patient’s clinical history and the ﬁndings
from the examination, like ‘pieces of jigsaw’ (Cardiff
28).
However, this need to combine clinical ﬁndings, along
with the lack of conclusive evidence to support diagnosis
and management of LRTI in primary care, led some
clinicians (particularly those in the Cardiff and Antwerp
network) to describe a zone of uncertainty in making
management decisions. Some felt that they never
reached certainty and were always working with proba-
bilities: “That feeling, that assessing.it of course always
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(Antwerp 77). This was because they did not know for
certain, in routine practice, whether they were dealing
with a bacterial or viral infection: “Due to the fact that I
don’t have a bacteriologic diagnosis, I work only with
probabilities” (Balatonfu ¨red 328). This led to some
questioning the rationality and accuracy of their decision
making: “There’s always a grey area.there are always
going to be umm combinations of symptoms and signs
that do not persuade you totally that this person requires
antibiotics and then your judgement is based upon many
things that are not always logical” (Cardiff 42).
Despite this uncertainty, clinicians easily listed clinical
factors they would usually consider. They handled this
uncertainty in different ways. Some gave a systematic
standardised formula of factors they would consider,
particularly in relation to the examination of the patient:
“What I do mostly, it is also a bit working in a standard-
ized way.So mostly, when I do it well, then it will be like
this, so ﬁrst quickly looking at the throat, and then
quickly, er, listening to the heart, and then to the lungs.
And what I mostly do as well, is measuring a blood
pressure” (Antwerp 63). Some clinicians accepted that
uncertainty was ‘part of the job’ as a GP and lived with it,
as this clinician illustrates; “As a family doctor you have
learned to deal with limits and uncertainties. That is part
of our profession. If you don’t feel good about that, then
you don’t stay a family doctor” (Antwerp 147). One
clinician in Antwerp handled uncertainty by considering
the patient’s state in relation to thresholds of different
levels of activity, rather than try to apply a diagnostic
label to the patient, which he felt was impossible to make
with any certainty. These thresholds ranged from simply
treating the symptoms to prescribing antibiotics, refer-
ring the patient and ﬁnally hospitalisation: “The most
important choice is, do you restrict yourself to taking
care of the symptoms or do you proceed to antibiotics, or
referral, hospitalisation and so on. So, in the end.have
your limits been crossed in order to take action.Giving
that name, like, ouch, this is a bronchitis, or, ouch, this is
a pneumonia, certainly with a stethoscope I am not
capable of determining that, so I consciously don’t really
make a choice to use those terms” (Antwerp 147).
Clinicians’ accounts of decision making did not
necessarily rely on making a diagnosis ﬁrst (with some
clinicians emphasising the uncertainty and difﬁculty in
conﬁrming an accurate diagnosis in practice). Clinicians
varied their focus when presented with a patient with
symptoms of LRTI; some placed an emphasis on iden-
tifying a diagnostic label, some on distinguishing the
cause of the infection (viral vs bacterial), some on
deciding on management and others doing all these
simultaneously.
Use of point of care tests and uncertainty
All clinicians in the Tromsø network reported routinely
using a C reactive protein (CRP) point of care test due to
the ‘extra information’ this provided for the immediate
decision on whether or not to prescribe antibiotics.
However, many clinicians in the Tromsø-based network
also expressed caution and awareness of the dangers of
over-reliance on the test when deciding about
prescribing antibiotics. Clinicians cautioned against
‘treating a CRP result’ rather than the patient and
misinterpreting and responding to misleading CRP
results.
In contrast, CRP tests were not routinely done in the
remaining eight networks. The majority of tests, for most
networks, were analysed in a location remote to the
primary care centre (usually a laboratory or hospital)
and therefore did not inﬂuence immediate management
decisions.
DISCUSSION
Principal ﬁndings
This trans-European study used qualitative methods to
explore reported, rather than actual, practice and
allowed clinicians to reﬂect on the importance of
different clinical factors rather than reproduce a list of
categories pre-determined by researchers.
Chest auscultation was the most consistently
mentioned examination procedure used to guide
decisions, a ﬁnding in keeping with previous
research
8 15 16 19 20 and with the GRACE-01 observa-
tional study conducted within these same networks
where auscultation was performed on 99% (n¼2690) of
the patients who attended with symptoms of acute
cough. Clinicians reported listening for a wide variety of
auscultationary abnormalities, implying a lack of consis-
tency in identifying and interpreting ﬁndings.
Hopstaken and colleagues
21 found that the signiﬁcance
of abnormal auscultation was overestimated and associ-
ated with inappropriate antibiotic prescribing. The
diagnostic importance of auscultation abnormalities may
be overestimated.
22 23 Normal chest auscultation might
be more useful clinically, as auscultation may have
a greater negative than positive predictive value.
24
The presence of fever was also used in decision
making. However, there was some variation in how long
patients should have had fever for it to be ‘meaningful’,
and there were differences in reported practice as to
when temperature was taken. Some clinicians reported
that asking patients their temperature was enough. This
suggests a lack of standardised practice in clinical
method.
A notable feature in clinicians’ decision making was
the inﬂuence of discoloured sputum on management.
Many clinicians talked about this but few explicitly
questioned the value of sputum colour in guiding deci-
sions. Yellow and/or green sputum has previously been
found to be associated with antibiotic prescribing for
RTI, despite it being a weak diagnostic marker for
bacterial infection.
9 20 25 26 We found an emphasis on
combining factors and therefore focusing on one
ﬁnding and describing poor predictive value for one sign
or symptom is not consistent with the clinical method
followed by clinicians. Individual items are not acted
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regarding severity assessment and management.
Additional tests were not reported as generally inﬂu-
encing the immediate management decision, particu-
larly in relation to decision to prescribe antibiotics, with
the exception of the Tromsø network. While all clini-
cians in this network reported that tests were routinely
carried out due to the value of the extra information
they provided, they still expressed caution about over-
reliance on the test.
20 27 Clinicians in other networks
mentioned an array of potential investigations that could
be ordered but these were not used routinely and did
not inﬂuence empirical management.
We found that clinicians across all networks appeared
to combine clinical factors assigning them different
weightings to guide decisions. This ﬁts with Atkinson’s
notion of diagnosis as professional detective work or
a ‘puzzle-solving activity’.
28 However, Fischer et al
16
found that family practitioners performed a ‘simpliﬁed
process’, in line with simple heuristics that led to
a decision to prescribe antibiotics (or not). For some
clinicians, decision making was clearly not a process in
which the various factors are taken and considered in
a step-by-step manner. Rather, decision making was
presented as a blend of accumulating factors used to
discount certain possibilities and point in the direction
of others. While this might sound chaotic, individual
clinicians talked about working in a systematic or
standardised way and had developed their own method
to ensure all factors that they felt were relevant were
considered. This indicated that management decisions
are complex and may explain why they differ from
clinician to clinician.
29
While the issue of diagnostic and management uncer-
tainty has been acknowledged by some clinicians and
identiﬁed in research, clinicians largely described their
own routine processes that they had developed and
followed in order to make decisions.
8 15 19 30 31 It is
possible that, rather than focus on the uncertainty, clini-
cians developed ways to handle this uncertainty through
their own ritual of clinical processes and practice.
However, overall, important variation does not seem to
occur in the clinical factors clinicians report as inﬂu-
encing their antibiotic prescribing decisions, with the
exception of the near patient test in the Tromsø
network. It is possible that they weigh and integrate
factors differently in different European settings, but it is
unlikely that variation in management can be satisfac-
torily explained by these subtle differences and clinical
method alone and there is a need to consider non-clin-
ical factors to understand variation across European
networks. We will report on clinicians’ accounts of the
non-clinical factors that shape antibiotic prescribing in
a further paper.
Strengths and limitations
This is the ﬁrst study to use semi-structured qualitative
interviews to capture clinicians’ views about LRTI
management across a broad range of contrasting Euro-
pean countries. It allowed us to explore practice in
different cultural and healthcare delivery systems.
The clinicians who participated were all afﬁliated to
a research network and so may not have been repre-
sentative of all GPs in their country. Qualitative research
methods aim to generate further understanding rather
than generalise. They gather clinicians’ reports of prac-
tice, rather than actual practice. Qualitative methods
were chosen because our aim was to generate data
important to clinicians themselves rather than quantify
responses to questionnaire items identiﬁed by
researchers. By allowing clinicians to introduce and
elaborate on themes spontaneously, we were able to gain
an impression of the themes that held most prominence
to the clinicians themselves.
Implications
Clinicians clearly consider a range of clinical factors in
making a management decision for LRTI and manage
uncertainty by following their own formula to gather
evidence to inform their decision making. However, the
components used are similar across networks, except
Tromsø where CRP near patient testing is routinely used.
It is possible that standardising the way key components
of clinical method are used may help reduce unhelpful
variation in antibiotic prescribing decisions (especially
possible over-reliance on auscultationary abnormalities
and sputum colour). However, non-clinical factors may
also explain an important component of this unhelpful
prescribing variation.
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